Corporate Team

A Higher Brand of Management

Elite Clinical Network runs a tightly managed group of study sites that reflect the supervisory skills of a highly professional corporate team. Unlike the loose structure of an SMO, our organization relies upon hands-on attention to detail. Each management team member offers vast experience, research savvy and the skill to facilitate your studies in an efficient, expedient manner.

David Wilson III

Chief Operating Officer

As Chief Operating Officer, David has launched and managed several successful clinical research sites over the course of his 18-year career. He has worked in every facet of the industry, including conducting phase one studies with many leading CROs and Sponsors. His goal has always been to create a network of clinical sites unlike a SMO that is able to achieve high enrollment while ensuring the highest quality data. "Our success is contributed to having a well-educated and diverse corporate team that is able to keep its finger on the pulse at all times, unlike a SMO we are a hands-on organization that knows how to achieve high enrollment while providing high quality data"

Sarah St. John

Chief Commercial Officer

Sarah brings a unique blend of scientific expertise and business acumen to her role as Chief Commercial Officer at Elite Clinical Network. With a PhD in organic chemistry, she transitioned her career from drug discovery and development research to excel in strategic sales and marketing. Sarah has a track record of building high-achieving teams that ensure client success through effective communication and an immense focus on partnership. Sarah is dedicated to advancing human health, making her a transformative force in healthcare leadership at Elite Clinical Network

Diana Johnson

Vice President Human Resources

Diana brings over 10 years of Human Resources leadership experience to ECN, with an emphasis on developing HR programs in growth-oriented specialty healthcare organizations. With advanced training in occupational health, psychology and compliance, she's committed to developing equitable policies and procedures, while maintaining integrity and objectivity at all times. As a nationally recognized rare disease advocate, Diana is passionate about the advancement of clinical trial research and promoting patient accessibility to treatments.

Sanjay Gulati

Chief Executive Officer

Sanjay brings 15 years of professional and leadership experience to ECN. Among his broad investing and operating background in private equity, Sanjay has direct experience in the biopharmaceutical and Contract Research Organizations (CRO) space. He most recently helped scale and exit Genesis Research, a Real-World Evidence (RWE) and Health Economics & Outcomes Research (HEOR) focused organization. Sanjay strives to live by the "no job is too small or too big" motto and is passionate about empowering and partnering with other driven individuals to build scalable, sustainable, and impactful organizations.